Insider filing · AGL

Steven Sell bought $4.3M of agilon health (AGL)

Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Mar 18 2025), the stock returned +32.9% (delay-adjusted); from the execution session (Mar 14 2025), +39.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

SS Steven Sell CEO & President profile →

Steven Sell (CEO & President) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in AGL. Across 1 priced purchase filing, the average 21-session return was +39.9% from execution and +32.9% from disclosure (delay-adjusted; derived). The largest single filing was $4.3M of AGL (as filed, as filed), executed Mar 14 2025.

AGL AGL AGL · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→